Assignment of Assignor's Interest

Recorded: 2022-02-02 Pages: 4

Assignors

SUKUMAR, GOWRI

Executed: 2020-12-09

OSTOVIC, DRAZEN

Executed: 2020-12-09

Assignee

ITERION THERAPEUTICS, INC.

2450 HOLCOMBE BLVD., SUITE X, HOUSTON, TEXAS, 77021

Covered Properties (3)

Lyophilized Formulations of Tegavivint

Patent: 11,571,388 →

Application: 17/103,468 →

Publication: US 2022/0160635

Lyophilized Formulations of Tegavivint

Patent: 11,793,759 →

Application: 17/355,781 →

Publication: US 2022/0160636

Lyophilized Formulations of Tegavivint

Patent: 11,602,501 →

Application: 17/492,969 →

Publication: US 2022/0160637